Market report
Dermatological drug tenders in Czechia — market report, April 2025
Dermatological drug tenders in Czechia in April 2025: 8,045 tenders published (-9% month on month, +19% year on year), estimated at €6,934,584 in total, and 8,051 contracts awarded (-9% month on month, +19% year on year), worth €5,714,987 (awarded value). Buyers with the most tenders: Fakultní nemocnice Bulovka (2,329), Krajská nemocnice T. Bati, a. s. (1,977) and Krajská zdravotní, a.s. (811); most contracts won: ViaPharma s.r.o. (372), ROCHE s.r.o. (234) and Janssen-Cilag s.r.o. (152). On average 1.1 bids per contract; 90% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 8,045
- Contracts awarded
- 8,051
- Contract value awarded
- €5,714,987
- Bids per contract
- 1.1
The highlighted bar is April 2025. Hover a bar for its figure; the table below has every value.
| Figure | April 2025 | March 2025 | Change | April 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 8,045 | 8,827 | -9% | 6,740 | +19% |
| Estimated value | €6,934,584 | €167,261 | +4,046% | €1,849,242 | +275% |
| Buyers | 31 | 34 | -9% | 32 | -3% |
| Contracts awarded | 8,051 | 8,846 | -9% | 6,746 | +19% |
| Contract value (awarded) | €5,714,987 | €26,562,599 | -78% | €51,985 | +10,894% |
| Winners | 264 | 279 | -5% | 284 | -7% |
| Bids per contract | 1.1 | 1.4 | — | 3.7 | — |
| Single-bid contracts | 90% | 75% | — | 43% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 372 |
| 2 | ROCHE s.r.o. | 234 |
| 3 | Janssen-Cilag s.r.o. | 152 |
| 4 | Merck Sharp & Dohme s.r.o. | 142 |
| 5 | Amgen s.r.o. | 119 |
| 6 | AbbVie s.r.o. | 116 |
| 7 | Avenier a.s. | 113 |
| 8 | Takeda Pharmaceuticals Czech Republic s.r.o. | 110 |
| 9 | Gilead Sciences s.r.o. | 93 |
| 10 | BAYER s.r.o. | 77 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in April 2025?
- 8,045 (by 31 buyers); for comparison, March 2025: 8,827, April 2024: 6,740.
- Who won the most dermatological drug tenders in Czechia in April 2025?
- By number of contracts: ViaPharma s.r.o. (372), ROCHE s.r.o. (234), Janssen-Cilag s.r.o. (152), Merck Sharp & Dohme s.r.o. (142) and Amgen s.r.o. (119); 264 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in April 2025?
- Fakultní nemocnice Bulovka (2,329), Krajská nemocnice T. Bati, a. s. (1,977), Krajská zdravotní, a.s. (811), Fakultní nemocnice Brno (375) and Nemocnice České Budějovice, a.s. (297).
- How competitive were dermatological drug tenders in Czechia in April 2025?
- On average 1.1 bids per contract (20 contracts with a known number of bids); 90% of contracts had a single bid.
- What were the contracts worth in April 2025?
- €5,714,987 (awarded value, 8,051 contracts); median about €550,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.